(Q30459124)

14 August 2017

A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis (English)

1 reference

ORCID Public Data File 2021

14 August 2017

1 reference

1 reference

Masashi Mizokami

series ordinal

10

object named as

Masashi Mizokami

1 reference

14 August 2017

3

Yasuhito Tanaka

1 reference

14 August 2017

8

Michiie Sakamoto

1 reference

14 August 2017

1

Atsushi Kuno

1 reference

14 August 2017

4

Kiyoaki Ito

1 reference

14 August 2017

7

Shuhei Hige

1 reference

14 August 2017

9

Masayoshi Kage

1 reference

14 August 2017

11

Hisashi Narimatsu

1 reference

14 August 2017

Yuzuru Ikehara

2

1 reference

14 August 2017

Atsushi Matsuda

series ordinal

5

1 reference

14 August 2017

Satoru Sekiya

series ordinal

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

15 January 2013

1 reference

14 August 2017

1 reference

14 August 2017

3

1 reference

14 August 2017

1065

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

14 August 2017

start time

15 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Anti-fibrotic therapy: lost in translation?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Toward automated glycan analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Non-invasive assessment of liver fibrosis in chronic hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Hepatitis C pharmacogenetics: state of the art in 2010.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Diagnosis, management, and treatment of hepatitis C: an update

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3545220

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

20 June 2018

1 reference

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

A novel panel of blood markers to assess the degree of liver fibrosis

21 January 2018

1 reference

Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

21 January 2018

1 reference

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics

21 January 2018

1 reference

Multilectin assay for detecting fibrosis-specific glyco-alteration by means of lectin microarray

21 January 2018

1 reference

High-throughput profiling of the serum N-glycome on capillary electrophoresis microfluidics systems: toward clinical implementation of GlycoHepatoTest

21 January 2018

1 reference

LecT-Hepa: A triplex lectin-antibody sandwich immunoassay for estimating the progression dynamics of liver fibrosis assisted by a bedside clinical chemistry analyzer and an automated pretreatment machine.

21 January 2018

1 reference

Comparison of LecT-Hepa and FibroScan for assessment of liver fibrosis in hepatitis B virus infected patients with different ALT levels.

21 January 2018

1 reference

The HCV serum proteome: a search for fibrosis protein markers

21 January 2018

1 reference

Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling

21 January 2018

1 reference

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

21 January 2018

1 reference

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis

21 January 2018

1 reference

Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy

21 January 2018

1 reference

Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single center

21 January 2018

1 reference

Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Performance of Real-Time Strain Elastography, Transient Elastography, and Aspartate-to-Platelet Ratio Index in the Assessment of Fibrosis in Chronic Hepatitis C

21 January 2018

1 reference

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

21 January 2018

1 reference

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23323209

12 December 2020

inferred from PubMed ID database lookup

FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23323209

12 December 2020

inferred from PubMed ID database lookup

Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23323209

12 December 2020

inferred from PubMed ID database lookup

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SREP01065

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

23323209

1 reference